{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:04:02Z","timestamp":1781024642840,"version":"3.54.1"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR-CS-2012-032"],"award-info":[{"award-number":["NIHR-CS-2012-032"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation Chair in Cardiovascular and Diabetes Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"NIHR Leeds Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203331"],"award-info":[{"award-number":["NIHR203331"]}],"id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Right ventricular pacing (RVP) is associated with left ventricular systolic dysfunction (LVSD) and heart failure (HF). We investigated the prevalence and predictors of LVSD and adverse HF outcomes in patients undergoing de novo or replacement RVP for bradycardia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Prospective data were collected from 1024 patients receiving de novo (2014\u20132017, n = 514) or generator replacement (2008\u20132011, n = 510) RVP at a UK tertiary centre. Logistic regression models were used to identify predictors of LVSD, defined as left ventricular ejection fraction (LVEF) &amp;lt; 50%, and subsequent HF hospitalization (HFH) and all-cause mortality. Overall, 61% were male; mean age 76 \u00b1 11 years. De novo patients were more often male (66% vs. 56%) and more likely to have ischaemic heart disease (IHD; 31% vs. 14%) and diabetes (24% vs. 6%), but less likely to have atrial fibrillation (AF; 25% vs. 33%) than replacement patients (all P &amp;lt; 0.01). LVSD was present in 344 (37%) and was more frequent in de novo than replacement cases (20% vs. 17%, P &amp;lt; 0.01). Independent predictors of LVSD were IHD [odds ratio (OR) = 2.56, confidence interval (CI): 1.58\u20134.13] and ventricular pacing burden &amp;gt;80% (OR = 2.13, CI: 1.29\u20133.52). Over a median 30 (IQR: 16\u201342) months, 341 (33%) experienced HFH or death, more commonly after replacement than de novo RVP (25% vs. 8%, P &amp;lt; 0.01). Predictors of adverse outcomes included replacement status [hazard ratio (HR) = 2.27, CI: 1.78\u20134.16], older age, AF, and LVEF &amp;lt;50%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LVSD is common in RVP recipients and largely driven by comorbidities rather than pacing burden. Screening and targeted therapy in high-risk patients may improve outcomes and optimize resource use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjopen\/oeag069","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:38:33Z","timestamp":1776944313000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receiving\n                    <i>de novo<\/i>\n                    and replacement pacemaker therapy for bradycardia"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1364-8311","authenticated-orcid":false,"given":"Nurul H","family":"Abdul Samad","sequence":"first","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9588-191X","authenticated-orcid":false,"given":"John","family":"Gierula","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9793-1519","authenticated-orcid":false,"given":"Judith E","family":"Lowry","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2942-4574","authenticated-orcid":false,"given":"Sam","family":"Straw","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0634-4587","authenticated-orcid":false,"given":"Samuel D","family":"Relton","sequence":"additional","affiliation":[{"name":"Leeds Institute of Health Sciences, University of Leeds , Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-3885","authenticated-orcid":false,"given":"Stephe","family":"Kamalathasan","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7844-3600","authenticated-orcid":false,"given":"Richard M","family":"Cubbon","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T","family":"Kearney","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-7105","authenticated-orcid":false,"given":"Klaus K","family":"Witte","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-4621","authenticated-orcid":false,"given":"Maria F","family":"Paton","sequence":"additional","affiliation":[{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Cardiovascular Research Facility , F Floor, Jubilee Wing, Leeds General Infirmary, LS1 3EX, Clarendon Way, Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2026060912510868400_oeag069-B1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199804163381602","article-title":"Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing","volume":"338","author":"Lamas","year":"1998","journal-title":"N Engl J Med"},{"key":"2026060912510868400_oeag069-B2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European society of cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"},{"key":"2026060912510868400_oeag069-B3","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1540-8159.1992.tb03014.x","article-title":"The clinical relevance of electromyopotential oversensing in current unipolar devices","volume":"15","author":"Gross","year":"1992","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026060912510868400_oeag069-B4","first-page":"e350","article-title":"ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (writing committee to revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American association for thoracic surgery and society of thoracic surgeons","volume":"117","author":"Members","year":"2008","journal-title":"Circulation"},{"key":"2026060912510868400_oeag069-B5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0735-1097(94)90567-3","article-title":"Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology","volume":"24","author":"Lee","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"2026060912510868400_oeag069-B6","doi-asserted-by":"crossref","first-page":"A86-A","DOI":"10.1136\/heartjnl-2011-300198.154","article-title":"154 patients receiving standard pacemaker generator replacements frequently have impaired left ventricular function and exercise intolerance, related to the percentage of right ventricular pacing","volume":"97","author":"Begg","year":"2011","journal-title":"Heart"},{"key":"2026060912510868400_oeag069-B7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jacc.2018.06.017","article-title":"His bundle pacing","volume":"72","author":"Vijayaraman","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026060912510868400_oeag069-B8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jacep.2018.07.013","article-title":"The efficacy of his bundle pacing: lessons learned from implementation for the first time at an experienced electrophysiology center","volume":"4","author":"Bhatt","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2026060912510868400_oeag069-B9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/europace\/euad043","article-title":"EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific heart rhythm society (APHRS), Canadian heart rhythm society (CHRS), and LATIN AMERICAN HEART RHYTHM SOCIETY (LAHRS)","volume":"25","author":"Burri","year":"2023","journal-title":"Europace"},{"key":"2026060912510868400_oeag069-B10","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1093\/eurheartj\/ehac445","article-title":"Left bundle branch area pacing outcomes: the multicentre European MELOS study","volume":"43","author":"Jastrz\u0119bski","year":"2022","journal-title":"Eur Heart J"},{"key":"2026060912510868400_oeag069-B11","doi-asserted-by":"crossref","first-page":"euad019","DOI":"10.1093\/europace\/euad019","article-title":"Conduction system pacing, a European survey: insights from clinical practice","volume":"25","author":"Keene","year":"2023","journal-title":"Europace"},{"key":"2026060912510868400_oeag069-B12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.hroo.2020.03.002","article-title":"Left bundle branch pacing is the best approach to physiological pacing","volume":"1","author":"Padala","year":"2020","journal-title":"Heart Rhythm O2"},{"key":"2026060912510868400_oeag069-B13","doi-asserted-by":"crossref","first-page":"e008267","DOI":"10.1161\/CIRCEP.119.008267","article-title":"Bilateral bundle branch area pacing to achieve physiological conduction system activation","volume":"13","author":"Lin","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026060912510868400_oeag069-B14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.hrthm.2017.10.039","article-title":"Permanent his bundle pacing: recommendations from a multicenter his bundle pacing collaborative working group for standardization of definitions, implant measurements, and follow-up","volume":"15","author":"Vijayaraman","year":"2018","journal-title":"Heart Rhythm"},{"key":"2026060912510868400_oeag069-B15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"24","author":"Members: ATF","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026060912510868400_oeag069-B16","doi-asserted-by":"crossref","unstructured":"Wharton G, Steeds R, Allen J, Phillips H, Jones R, Kanagala P, Lloyd G, Masani N, Mathew T, Oxborough D, Rana B, Sandoval J, Wheeler R, O\u2019Gallagher K, Sharma V. A minimum dataset for a standard adult transthoracic echocardiogram: a guideline protocol from the British society of echocardiography. Echo Res Pract \u00a02015;2:G9\u2013G24.","DOI":"10.1530\/ERP-14-0079"},{"key":"2026060912510868400_oeag069-B17","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1161\/CIRCULATIONAHA.105.561423","article-title":"Influence of ejection fraction on cardiovascular outcomes in a broad Spectrum of heart failure patients","volume":"112","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"2026060912510868400_oeag069-B18","doi-asserted-by":"crossref","first-page":"e028613","DOI":"10.1136\/bmjopen-2018-028613","article-title":"Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial","volume":"9","author":"Paton","year":"2019","journal-title":"BMJ Open"},{"key":"2026060912510868400_oeag069-B19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/heartjnl-2013-304905","article-title":"Pacing-associated left ventricular dysfunction? Think reprogramming first!","volume":"100","author":"Gierula","year":"2014","journal-title":"Heart"},{"key":"2026060912510868400_oeag069-B20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2459\/JCM.0000000000000117","article-title":"Patients with long-term permanent pacemakers have a high prevalence of left ventricular dysfunction","volume":"16","author":"Gierula","year":"2015","journal-title":"J Cardiovasc Med"},{"key":"2026060912510868400_oeag069-B21","doi-asserted-by":"crossref","first-page":"e0259450","DOI":"10.1371\/journal.pone.0259450","article-title":"Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: a phase II randomised, controlled clinical trial","volume":"16","author":"Paton","year":"2021","journal-title":"PLoS One"},{"key":"2026060912510868400_oeag069-B22","first-page":"411","article-title":"What you see may not be what you get: a brief, nontechnical Introduction to overfitting in regression-type models","volume":"66","author":"Babyak","year":"2004","journal-title":"Psychosom Med"},{"key":"2026060912510868400_oeag069-B23","first-page":"481","volume-title":"Using multivariate statistics","author":"Tabachnick","year":"2007","edition":"Vol 5"},{"key":"2026060912510868400_oeag069-B24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1207\/s15327906mbr2603_7","article-title":"How many subjects does it take to do A regression analysis","volume":"26","author":"Green","year":"1991","journal-title":"Multivariate Behav Res"},{"key":"2026060912510868400_oeag069-B25","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/ejhf.2609","article-title":"Baseline clinical characteristics of heart failure patients with reduced ejection fraction enrolled in the BUDAPEST-CRT upgrade trial","volume":"24","author":"Merkely","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026060912510868400_oeag069-B26","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/eurheartj\/ehz584","article-title":"Incidence of heart failure after pacemaker implantation: a nationwide Danish registry-based follow-up study","volume":"40","author":"Tayal","year":"2019","journal-title":"Eur Heart J"},{"key":"2026060912510868400_oeag069-B27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). with the special contribution of the heart failure association (HFA) of the ESC","volume":"24","author":"Members: ATF","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026060912510868400_oeag069-B28","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1161\/CIR.0b013e318276ce9b","article-title":"2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities","volume":"127","author":"Epstein","year":"2013","journal-title":"Circulation"},{"key":"2026060912510868400_oeag069-B29","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1540-8167.2007.00907.x","article-title":"Biventricular versus right ventricular pacing in patients with AV block (BLOCK HF): clinical study design and rationale","volume":"18","author":"Curtis","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026060912510868400_oeag069-B30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1071-9164(99)90013-1","article-title":"Candesartan in heart failure\u2014assessment of reduction in mortality and morbidity (CHARM): rationale and design","volume":"5","author":"Swedberg","year":"1999","journal-title":"J Card Fail"},{"key":"2026060912510868400_oeag069-B31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41569-021-00605-5","article-title":"Heart failure with mid-range or mildly reduced ejection fraction","volume":"19","author":"Savarese","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"2026060912510868400_oeag069-B32","doi-asserted-by":"crossref","first-page":"e001585","DOI":"10.1136\/openhrt-2021-001585","article-title":"Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction","volume":"8","author":"Straw","year":"2021","journal-title":"Open Heart"},{"key":"2026060912510868400_oeag069-B33","doi-asserted-by":"crossref","first-page":"e70164","DOI":"10.1111\/echo.70164","article-title":"Sex differences in diastolic function following myocardial infarction on Doppler echocardiography","volume":"42","author":"Chan","year":"2025","journal-title":"Echocardiography"},{"key":"2026060912510868400_oeag069-B34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"2026060912510868400_oeag069-B35","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.hrthm.2005.05.015","article-title":"Percent right ventricular pacing predicts outcomes in the DAVID trial","volume":"2","author":"Sharma","year":"2005","journal-title":"Heart rhythm"},{"key":"2026060912510868400_oeag069-B36","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"Sweeney","year":"2003","journal-title":"Circulation"},{"key":"2026060912510868400_oeag069-B37","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1056\/NEJMoa013040","article-title":"Ventricular pacing or dual-chamber pacing for sinus-node dysfunction","volume":"346","author":"Lamas","year":"2002","journal-title":"N Engl J Med"},{"key":"2026060912510868400_oeag069-B38","first-page":"3115","article-title":"Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID)","volume":"288","author":"Wilkoff","year":"2002","journal-title":"Trial. JAMA"},{"key":"2026060912510868400_oeag069-B39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/heart.84.5.560","article-title":"Heart disease in the elderly","volume":"84","author":"Lye","year":"2000","journal-title":"Heart"},{"key":"2026060912510868400_oeag069-B40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","article-title":"Mortality from ischaemic heart disease by country, region, and age: statistics from world health organisation and united nations","volume":"168","author":"Finegold","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026060912510868400_oeag069-B41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/jcm12010099","article-title":"The prescription pattern of heart failure medications in reduced, mildly reduced, and preserved ejection fractions","volume":"12","author":"Rastogi","year":"2022","journal-title":"J Clin Med"},{"key":"2026060912510868400_oeag069-B42","doi-asserted-by":"crossref","first-page":"e012256","DOI":"10.1161\/CIRCIMAGING.120.012256","article-title":"Detrimental immediate-and medium-term clinical effects of right ventricular pacing in patients with myocardial fibrosis","volume":"14","author":"Saunderson","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026060912510868400_oeag069-B43","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/ejhf.3601","article-title":"Comorbidity trajectories before and after the diagnosis of heart failure: a UK biobank cohort study","volume":"27","author":"MacGowan","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026060912510868400_oeag069-B44","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"key":"2026060912510868400_oeag069-B45","first-page":"S17","article-title":"Heart failure due to ischaemic heart disease: epidemiology, pathophysiology and progression","volume":"33","author":"Cleland","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026060912510868400_oeag069-B46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(98)00297-6","article-title":"Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials","volume":"32","author":"Dries","year":"1998","journal-title":"JACC"},{"key":"2026060912510868400_oeag069-B47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1540-8167.2005.40766.x","article-title":"Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs","volume":"16","author":"Sweeney","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026060912510868400_oeag069-B48","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.hrthm.2023.03.1538","article-title":"2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure","volume":"20","author":"Chung","year":"2023","journal-title":"Heart Rhythm"},{"key":"2026060912510868400_oeag069-B49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1540-8159.2006.00422.x","article-title":"Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block","volume":"29","author":"Gillis","year":"2006","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026060912510868400_oeag069-B50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/europace\/eun035","article-title":"Managed ventricular pacing vs. Conventional dual-chamber pacing for elective replacements: the PreFER MVP study: clinical background, rationale, and design","volume":"10","author":"Quesada","year":"2008","journal-title":"Europace"},{"key":"2026060912510868400_oeag069-B51","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJM195911052611904","article-title":"An intracardiac pacemaker for stokes-adams seizures","volume":"261","author":"Furman","year":"1959","journal-title":"N Engl J Med"},{"key":"2026060912510868400_oeag069-B52","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/eur365","article-title":"Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing","volume":"14","author":"Nielsen","year":"2012","journal-title":"Europace"},{"key":"2026060912510868400_oeag069-B53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/anec.12062","article-title":"First-degree AV block\u2014an entirely benign finding or a potentially curable cause of cardiac disease?","volume":"18","author":"Holmqvist","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026060912510868400_oeag069-B54","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/eurheartj\/ehu304","article-title":"Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the protect-pace study","volume":"36","author":"Kaye","year":"2015","journal-title":"Eur Heart J"},{"key":"2026060912510868400_oeag069-B55","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/europace\/euy058","article-title":"Permanent his-bundle pacing: a systematic literature review and meta-analysis","volume":"20","author":"Zanon","year":"2018","journal-title":"EP Europace"},{"key":"2026060912510868400_oeag069-B56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ehjci\/jead296","article-title":"Left bundle branch pacing better preserves ventricular mechanical synchrony than right ventricular pacing: a two-centre study","volume":"25","author":"Mao","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026060912510868400_oeag069-B57","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ehf2.12315","article-title":"Rationale and design of the randomized multicentre his optimized pacing evaluated for heart failure (HOPE-HF) trial","volume":"5","author":"Keene","year":"2018","journal-title":"ESC Heart Fail"},{"key":"2026060912510868400_oeag069-B58","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2018.02.048","article-title":"Clinical outcomes of his bundle pacing compared to right ventricular pacing","volume":"71","author":"Abdelrahman","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026060912510868400_oeag069-B59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1540-8159.2010.02951.x","article-title":"Safety and performance of a system specifically designed for selective site pacing","volume":"34","author":"Zanon","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026060912510868400_oeag069-B60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.hrthm.2014.10.021","article-title":"Permanent his-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice","volume":"12","author":"Sharma","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026060912510868400_oeag069-B61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jacep.2015.09.012","article-title":"Electrophysiologic insights into site of atrioventricular block: lessons from permanent his bundle pacing","volume":"1","author":"Vijayaraman","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2026060912510868400_oeag069-B62","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jacep.2020.05.008","article-title":"Comparison of left bundle branch and his bundle pacing in bradycardia patients","volume":"6","author":"Hua","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"2026060912510868400_oeag069-B63","author":"Whinnett"},{"key":"2026060912510868400_oeag069-B64","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/europace\/eut041","article-title":"Incidence and predictors of heart failure hospitalization and death in permanent pacemaker patients: a single-centre experience over medium-term follow-up","volume":"15","author":"Mazza","year":"2013","journal-title":"Europace"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/advance-article-pdf\/doi\/10.1093\/ehjopen\/oeag069\/68172231\/oeag069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/3\/oeag069\/68172231\/oeag069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/3\/oeag069\/68172231\/oeag069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:51:23Z","timestamp":1781023883000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeag069\/8663703"}},"subtitle":[],"editor":[{"given":"Frieder","family":"Braunschweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeag069","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,27]]},"article-number":"oeag069"}}